Journal article

Leptin in the pathophysiology of human obesity and the clinical potential of leptin-based therapy.

AW Thorburn, DA Ainslie, B Fam, J Proietto

BioDrugs | Published : 2000

Abstract

Leptin is a circulating hormone that is secreted in proportion to fat mass. It can reduce bodyweight by activating signalling molecules in the brain. Leptin appears to affect bodyweight primarily by decreasing food intake; there is no direct evidence that it significantly influences energy expenditure in humans. Its discovery in 1994 raised the possibility that it may be a useful, satiety-inducing, anti-obesity drug. However, treating obese patients with leptin alone does not induce substantial bodyweight loss because most obese patients are insensitive to leptin and are not leptin deficient. In combination with diet therapy, however, leptin treatment has the potential to eliminate the drama..

View full abstract

University of Melbourne Researchers

Grants

Citation metrics